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E-mail address: yyoneda@anat3.med.osaka-u.ac.jpThe small GTPase Ran plays important roles in multiple aspects of cellular function. Maximal Ran-
GAP activity is achieved with the aid of RanBP1 and/or presumably of RanBP2. Here, we show that
RanBP1-knockout mice are unexpectedly viable, and exhibit male infertility due to a spermatogen-
esis arrest, presumably caused by down-regulation of RanBP2 during spermatogenesis. Indeed, siR-
NA-mediated depletion of RanBP2 caused severe cell death only in RanBP1-deﬁcient MEFs,
indicating that simultaneous depletion of RanBP1 and RanBP2 severely affects normal cell viability.
Collectively, we conclude that the dramatic decrease in ‘‘RanBP’’ activity impairs germ cell viability
and affects spermatogenesis decisively in RanBP1-knockout mice.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Small GTPase Ran [1] plays important roles not only in funda-
mental cellular activities (nucleo-cytoplasmic transport, mitotic
spindle assembly, and nuclear envelope formation [2–8]), but also
in tissue activities such as nerve cell response to axon injury [9].
The asymmetric distribution of RanGTP in the nucleus and RanGDP
in the cytoplasm is regulated by nuclear RCC1 (RanGEF) [1] and
cytoplasmic RanGAP (=GTPase activating protein) [10]. In addition,
however, biochemical analyses have shown that the activity of
RanGAP is achieved with the aid of a Ran binding protein, RanBP1
[11]. Cytoplasmic RanBP1 serves as a crucial cofactor for stimulat-
ing RanGAP activity [12] by dissociating RanGTP-containing com-
plexes that exit from the nucleus [13] (Fig. S1). Although
Caenorhabditis elegans and Drosophila melanogaster do not have di-
rect homologues of RanBP1 [6], Saccharomyces cerevisiae possesses
a RanBP1 homologue (Yrb1) as an essential gene. Temperature-sen-
sitive mutants of Yrb1 show deﬁciency in nuclear import and poly
A+ RNA export activity [14,15]. Among identiﬁed Ran binding pro-
teins in mammals, only Ran binding protein 2 (RanBP2 [16]; also
called Nup358, a giant nucleoporin) contains RanBP1-like domainschemical Societies. Published by E
s Laboratory, Department of
iences, Osaka University, 1-3
6879 4609.
(Y. Yoneda).that show high afﬁnity to Ran, so RanBP2 is biochemically pre-
dicted to be the sole functional substitute for RanBP1 [2–8]. In
addition, it has recently been demonstrated that the null allele of
the mouse RanBP2 gene causes embryonic lethality [17,18].
Although the functions of RanBP1 have been well investigated at
the cellular level [2–8,19,20], its roles at the level of the organism
remain to be understood.
2. Materials and methods
2.1. Cell culture
Mouse embryonic ﬁbroblasts (=MEFs) were cultured in DMEM
supplemented with 10% FBS, at 37 C, 5% CO2.
2.2. Preparation of tissue and cell lysates
Fresh tissues obtained from 12-week old male mice or MEFs
were lysed with buffer (4 M Urea, 50 mM Tris–HCl (pH 8.0),
150 mM NaCl, 0.1% SDS, 1 mM EDTA with 10 lg/ml each of leupep-
tin, aprotinin, and pepstatin), and after centrifugation at
15 000 rpm for 10 min, the supernatant was used.
2.3. Generation of RanBP1-knockout mice
The targeting vector was constructed with the use of pMulti-ND
1.0 vector (a kind gift from Dr. J. Takeda and T. Ijiri) containing thelsevier B.V. All rights reserved.
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diphtheria toxin A chain (DT) as a negative selection marker. The
50 short arm spanned exon 1 and the 30 long arm included exon 3
and exon 4. The short and long arms were cloned into the pMulti-
ND-1.0 plasmid. The targeting construct was electroporated into
D3 embryonic stem (ES) cells. RanBP1 mutant cells obtained by
homologous recombination were identiﬁed by PCR and Southern
blot analysis. Targeted ES cell clones were microinjected into
C57BL/6 blastocists to generate chimeric mice. Chimeras were then
mated to C57BL/6 mice for germline transmission.2.4. Southern blot and PCR analysis
Southern blot hybridization was used to conﬁrm short-arm
recombination in theembryonic stemcells using standardprotocols.
Speciﬁcally, targeted clones were identiﬁed using a 50 external
probe, which detects the change of a 9.6 kb WT BamHI/NdeI frag-
ment to a novel 3.5 kb BamHI/NdeI fragment. To conﬁrm long-arm
recombination, long arm PCRwas performed using LA-TaqTM (TaKa-
Ra) according to the manufacturer’s instructions, with the shared
primer (see Fig. 1A) 1(50-GTTTCTCCTCAGACTTCTCTTCAGCCTCC-30)
and three pairs of primers. 2(50-TCTGTTGTGCCCAGTCATAGCCGAA-
TAGCC-30) to amplify a 8 kb PCR product, 3(50-TTGGCGCCTACC
GGTGGATGTGGAATGTGTG-30) to amplify a 7.6 kb PCR product,
4(50-GCTACTTCCATTTGTCACGTCCTGCACGACG-30) to amplify a
7.7 kb PCR product, respectively.
PCR products were resolved on 1% agarose gels.Fig. 1. Generation of RanBP1-knockout mice. (A) Genomic organization and targeting str
analysis (30 arm) of WT and RanBP1+/ ES cells. (C) Immunoblot of brain lysates from W
RanBP1+/+, +/, and / mice.2.5. Genotyping of the offspring was performed to detect the WT and
mutant alleles
For genotyping PCR (see Fig. 1A), the shared primer (3) (50-AC-
CCATTGATGTTTGAGTGTGTAGGAGTGTC-30) was designed up-
stream of the deleted region. This primer can pair with WT
allele-speciﬁc primer (2) (50-CTCATCTGCATTCTCTGTGGAAGTAT-
CATGG-30) to amplify a 300 bp PCR product or with the targeted
allele-speciﬁc primer (1) (50-GCCTTCTATCGCCTTCTTGACGAGTT
CTTC -30) in the neo cassette to amplify a 430 bp fragment from
the mutant allele. PCR was performed with rTaqTM (TaKaRa)
according to the manufacturer’s instructions, and PCR products
were resolved on 2% agarose gels.
2.6. Continuous breeding assay
(Male) 8-week old RanBP1+/ and / male mice were mated
with two wild-type (=WT) female mice and the cumulative num-
ber of progeny was counted for the period indicated.
(Female) 8-week old RanBP1+/ and / female mice were mated
with three RanBP1+/ male mice and the cumulative number of
progeny was counted for the period indicated.
2.7. Histology of testis sections
Fresh mouse testis and epididymis were ﬁxed in 10% formalin
neutral buffer solution, embedded in parafﬁn. Sections (7 lm)
were stained with Hematoxilin-Eosin (HE).ategy for RanBP1 gene disruption. (B) Southern blot analysis (50 arm) and PCR-based
T and RanBP1/ mice (GAPDH as a loading control). (D) PCR-based genotyping of
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Testis sections (8 lm) of RanBP1+/ and RanBP1/ male mice
were assayed for in Situ TUNEL assay using in situ Apoptosis Detec-
tion Kit (TaKaRa).
2.9. Age-blot analysis
Testis from wild-type (WT) male mice of 1–5 weeks of age were
lysed in RIPA buffer (10 mM Tris–HCl (pH 7.6), 0.15 M NaCl, 0.1%
SDS, 0.1% sodium deoxycholate, 1% NP-40).
2.10. Antibodies
Ran (Sigma, ARAN1), RanBP1 (Santa Cruz, M-45), RanBP2 (Cov-
ance, mAb414 for immunoblot) (abcam for immnohistochemstry),
RanGAP (Zymed Laboratories), RCC1 (Santa Cruz, N-19), Actin (San-
ta Cruz, C-11), GAPDH (Ambion, Cat#4300).
2.11. Proliferation and viability analyses of MEFs and procedures of
small interfering RNA (=siRNA) treatment
For proliferation analysis, 1  104 MEFs (passage 3) were plated
in triplicate on 12-well plates. The next day, MEFs were transfected
with 15 nM siRNA-oligonucleotide against mouse RanBP2 (50-
CCAGUCACUUACAAUUAAATT-30), and luciferase (50-AGCUU-
CAUAAGGCGCAUGCTT-30) using LipofectamineTM RNAiMAX (Invit-
rogen). For proliferation analysis, trypsinized MEFs were counted
at 1 to 4 days after transfection. For viability analysis, MEFs (96 h
after transfection) were trypsinized, centrifuged, and the dead cell
proportion was judged by trypan-blue staining.
2.12. Statistical analysis
The student’s t-test (two-tailed) was used.
3. Results and discussion
3.1. RanBP1-knockout mice are viable
To know the functions of RanBP1 at the organism level, we ﬁrst
examined the expression levels of the RanBP1 protein in various
mouse tissues. We found that RanBP1 was ubiquitously expressed
in the tissues examined (Fig. S2). In order to elucidate in vivo roles
of RanBP1, we next generated RanBP1-knockout mice utilizing
mouse embryonic stem (ES) cells (Fig. 1). Surprisingly, against
our expectation and in contrast to the case of RanBP2-knockout
mice, RanBP1/ mice were born alive, albeit at a lower frequency
than would be expected from Mendel’s Law (+/+: +/: /
 = 1:1.91:0.25 (n = 360), on a mixed background including
C57BL/6 and 129 alleles). Western-blot analysis of RanBP1/ brain
lysate conﬁrmed the complete absence of RanBP1 protein (Fig. 1C),
indicating that RanBP1 is not necessarily essential in mice, unlike in
budding yeast, although RanBP1 apparently has some effects on
mouse embryogenesis.
3.2. RanBP1-knockout mice show growth retardation and male
infertility
However, we noticed that at birth, RanBP1/ mice had small
body size without any apparent morphological abnormalities. This
body weight deﬁcit became more pronounced as the mice aged. At
the age of 12 weeks, RanBP1/ mice showed 32% body weight
reduction, as compared to WT littermates (Fig. 2A and B). We also
observed a few severe cases of RanBP1/ mice that were 50–60%smaller than their WT littermates (Fig. 2C). Additionally, RanBP1/
 mice exhibited male-speciﬁc infertility (Fig. 3A and B). Indeed,
when adult RanBP1/ male mice were mated to WT female mice
(C57BL/6), none of the female mice conceived (Fig. 3A), although
these mice copulated normally, as evidenced by the formation of
vaginal plugs (data not shown). On the other hand, RanBP1/ fe-
male mice were not infertility (Fig. 3B). Therefore, in this study,
we focused on examination of testis development in the RanBP1/
 mice.
3.3. Male infertility of RanBP1-knockout mice appears to be caused by
the decrease of RanBP2 at the stage of elongating spermatids in the
context of RanBP1-deﬁciency
Mouse spermatogenesis is a complex process that takes
35 days after birth. The process involves three major events: pro-
liferation of spermatogonial cells, meiotic division of spermato-
cytes, and differentiation from haploid spermatids to mature
sperm [21,22]. Detailed histological analysis revealed that the
germ cells of RanBP1/ male mice completed meiosis and formed
round spermatids but gradually ceased to differentiate, resulting in
impairment of spermatogenesis around the time of spermatid
elongation; only few elongated spermatids were observed
(Fig. 3C–E), and the epididymides of RanBP1/mouse testis lacked
mature sperm (Fig. 3F and G). Furthermore, TUNEL assay revealed
that there were 5.54 ± 0.86 (mean ± S.E.) apoptotic cells/tubule in
the testis of RanBP1/ mice, as compared to and 1.30 ± 0.28 in
RanBP1+/ mice (Fig. S3A). In RanBP1/ mice, round spermatids
or spermatocytes were detected in seminiferous tubules, and some
sperm nuclei in the tubule were detected near the tubule walls, but
not in the center (Fig. S3B and C).
Next, in order to understand how the decisive spermatogenesis
defect occurred at the stage of spermatid formation in RanBP1/
testis, we analyzed the expression patterns of Ran and RanGTPase
partners (RanBP1, RanBP2, RanGAP, and RCC1) during mouse sper-
matogenesis using testis lysates from 1 to 5 week old WT mice. We
found that the expression levels of RanBP1, RanGAP, RCC1, and Ran
did not change signiﬁcantly during spermatogenesis (Fig. 4A–F). In
contrast, RanBP2 protein showed a dramatic decrease at the stage
of spermatid elongation (corresponding to 4 weeks old) (Fig. 4C),
just when RanBP1/ germ cells ceased to differentiate. The expres-
sion pattern of RanBP2 was also conﬁrmed by immunohistochem-
istry in WT testis sections (Fig. S4).
Since it has been established biochemically that both RanBP1
and RanBP2 function as positive regulators for RanGAP activity,
the depletion of both factors should cause a severe defect in
RanGTPase activity, damaging diverse cellular functions mediated
by Ran. Therefore, it seems possible that the decisive defect in
spermatogenesis observed in RanBP1/ testis is caused by pertur-
bation of RanGTPase activity in germ cells when RanBP2 is down-
regulated in the context of RanBP1-deﬁciency.
3.4. RanBP2-depletion suppresses cell viability in RanBP1/MEFs
To explore this possibility and owing to technical difﬁculties in
culturing male germ cells, we established RanBP1/ MEFs and
introduced siRNA oligo duplexes against RanBP2 to mimic the sit-
uation of spermatids in RanBP1/ testis (Fig. 5A). As shown in
Fig. 5B, at 48 h after siRNA treatment, RanBP2-speciﬁc siRNA-trea-
ted WT MEFs showed comparable proliferation as compared to
control siRNA-treated WT MEFs. In contrast, RanBP2-speciﬁc siR-
NA-treated RanBP1/ MEFs showed decreased proliferation as
compared to control siRNA-treated RanBP1/ MEFs. In addition,
72 and 96 h after siRNA treatment, RanBP2-siRNA-treated Ran-
BP1/ MEFs showed a dramatic decrease in proliferation as
Fig. 2. RanBP1-knockout mice are viable. (A and B) Growth curves of male (A) and female (B) mice (means ± S.D.). (C) Appearance of RanBP1+/+ (left) and RanBP1/ (right)
male littermates (postnatal day 11 and day 24).
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eration of RanBP2-speciﬁc siRNA-treated WT MEFs was decreased
to a lesser extent (Fig. 5B). Furthermore, we found that cell viability
was signiﬁcantly decreased in RanBP2-speciﬁc siRNA-treated Ran-
BP1/ MEFs compared with RanBP2-speciﬁc siRNA-treated WT
MEFs (86.2% vs. 17.4%, P = 1.36  105) (Fig. 5C). These results indi-
cate that RanBP2-depletion in the context of RanBP1-deﬁciency
strongly suppresses cell proliferation and viability, while down-
regulation of RanBP2 alone affects them to a lesser extent.
Based on these experiments, in RanBP1-knockout mice, it is rea-
sonable to suppose that the decisive impairment of spermatogen-
esis observed at the stage of spermatid elongation is caused by
the loss of ‘‘RanBP’’ activity due to the simultaneous depletion of
RanBP1 and RanBP2, while the apoptotic signals at the stage of
spermatocyte would be the inﬂuence of RanBP1-deﬁciency alone,
and that the signals near the tubule walls may show the degraded
products of sperm nuclei that were phagocytosed by Sertoli cells as
in the case of meichroacidin (MCA)-knockout mice [23].
4. Discussion
This study showed that RanBP1-knockout mice are viable and,
during spermatogenesis, the proliferation of spermatogonial cellsand the meiotic division of spermatocytes do not necessarily re-
quire RanBP1, presumably because of functional complementation
by RanBP2. However, we also observed that RanBP1-knockout
mice are born at a lower ratio than 25%, and exhibit growth retar-
dation after birth. These data indicate that RanBP1 has some func-
tion(s) that are not completely compensated by RanBP2.
In contrast to the results reported herein, previous studies have
reported that RanBP2-knockout mice display an embryonic lethal
phenotype [17,18]. These results indicate that RanBP1 cannot com-
pensate for the function of RanBP2 during embryogenesis, suggest-
ing that RanBP2 is more critical than RanBP1 for the RanGTPase
activity and/or that RanBP2possesses independent roles. RanBP2 lo-
cates at the cytoplasmic rim of the nuclear pore complex (=NPC),
whereas RanBP1 is dispersed in the cytoplasm [2–8], it is therefore
possible that RanBP2 ﬁrst captures outgoing RanGTP-containing ex-
port complexes and SUMO (=small ubiquitin-like modiﬁer)-modi-
ﬁed RanGAP that is associated with RanBP2 immediately mediates
GTP hydrolysis by Ran to dissociate the export complex, while Ran-
BP1 may function as a ‘‘back-up’’ factor for this process.
The human RanBP1 gene is located at chromosome 22q11.2. Pa-
tients of DiGeorge syndrome (DGS), a frequent hereditary disease
that exhibits a wide range of symptoms, commonly lack the
22q11.2 region in a haplo-insufﬁcient manner [24]. Although
Fig. 3. Male infertility of RanBP1-knockout mice. (A and B) Continuous breeding assay starting at 8 weeks of age, showing cumulative number of progeny (male (A) and
female (B)). (C and D) Haematoxylin and eosin (HE) staining of seminiferous tubules from RanBP1+/+ (C) and RanBP1/ (D) mice (scale bar 100 lm). The number of round
spermatids decreased, and elongated spermatids were rare in the center of seminiferous tubules (Red arrow heads). The red arrow indicates spermatocytes of seminiferous
tubules. (E) Higher magniﬁcation images of the locus indicated by a red star in seminiferous tubules from RanBP1/ testis. Elongated spermatids were rare in the center of
seminiferous tubules (Blue star); tails and a few immature heads of elongated spermatids were found in seminiferous tubules. Blue arrows indicate spermatocytes and
meiotic phase. Blue arrowheads indicate round spermatids (scale bar 25 lm). (F and G) HE staining of epididymis from RanBP1+/+ (F) and RanBP1/ (G) mice (scale bar
100 lm).
F
Fig. 4. Expression patterns of RanGTPase cycle regulators during mouse spermatogenesis. Lanes 1–5 are testis lysate samples fromWTmice of 1–5 weeks of age, respectively.
Ran, (B) RanBP1, (C) RanBP2, (D) RanGAP, (E) RCC1, (F) actin (a loading control).
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range of DGS symptoms has not yet been identiﬁed [24]. Although
no case of a male DGS patient who exhibited infertility has been re-
ported, it may be meaningful to determine whether some DGS pa-
tients display infertility owing to a mutation(s) in the other allele
of the RanBP1 gene. Intriguingly, some DGS patients have been
clinically reported to show growth retardation [25], reminiscent
of the small body size observed in the RanBP1-knockout mice.
Thus, the growth retardation symptom of DGS may be explained
by the reduced expression of RanBP1.
On the other hand, it has recently been reported that cultured
peripheral sensory neurons respond to axon injury by locally reg-ulating the RanGTPase cycle [9], raising the possibility that Ran-
BP1-knockout mice may show some neuronal defects just after
injury.
Finally, recent studies have reported that siRNA-mediated
depletion of RanBP1 alone leads to signiﬁcant cell death in some
cancer cell lines (HeLa, U2OS) [19,20]. Intriguingly, microarray
analyses have revealed that RanBP1 is overexpressed in various tu-
mor specimens, such as squamous lung carcinoma and esophageal
carcinoma [3]. These observations also suggest that RanBP1 plays
some roles independent of RanBP2 at least in some cancer cells.
RanBP1-knockout mice will be of use to elucidate the entire com-
plement of RanBP1 functions.
Fig. 5. RanBP1/ MEFs proliferate normally and siRNA-mediated RanBP2-depletion causes severe damage speciﬁcally in RanBP1/ MEFs. (A) Conﬁrmation of RanBP2-
depletion in RanBP2-siRNA-treated MEFs by immunoblot analysis ((1) mock (2) control-siRNA-treated (3) RanBP2-siRNA-treated). (B) Growth curves of WT and RanBP1/
MEFs (Passage 3) treated with control- or RanBP2-siRNA for 4 days after siRNA transfection (⁄P = 7.52  103; ⁄⁄P = 2.40  104; #P = 7.93  103; ##P = 0.722). (C) Cellular
viability determination by trypan-blue staining (⁄P = 5.05  106; ⁄⁄P = 2.87  10-5; ⁄⁄⁄P = 1.36  105; #P = 0.0431).
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